Copy number gain at 8q12.l-q22.l is associated with a malignant tumor phenotype in salivary gland myoepitheliomas

Genes Chromosomes and Cancer

Volumn 48, Issue 2, 2009, Pages 202-212

  Vékony, Hedy ^a   Röser, Kerstin ^b   Löning, Thomas ^b   Ylstra, Bauke ^c   Meijer, Gerrit A ^c   Van Wieringen, Wessel N ^d   Van De Wiel, Mark A ^c,d   Carvalho, Beatriz ^c   Kok, Klaas ^e   Leemans, C René ^c   Van Der Waal, Isaäc ^a   Bloemena, Elisabeth ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR;

ADULT; AGED; ARTICLE; CARCINOMA; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME NUMBER; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MYOEPITHELIOMA; PHENOTYPE; PRIORITY JOURNAL; SALIVARY GLAND TUMOR;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 8; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; MYOEPITHELIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; SALIVARY GLAND NEOPLASMS; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEINS;

EID: 59949090393     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20631     Document Type: Article

References (55)

1. Atayar C, Kok K, Kluiver J, Bosga A, Van den Berg E, Van der Vlies P, Blokzijl T, Harms G, Davelaar I, Sikkema-Raddatz B, Martin-Subero JI, Siebert R, Poppema S, Van den Berg A. 2006. BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. Hum Pathol 37:675-683.
2. Barnes L, Eveson JW, Reichart P, Sidransky D. 2005. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press, pp. 259-260.
3. Buffart TE, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Schaaij-Visser TB, Eijk PP, Van Grieken NC, Ylstra B, Van de Velde CJ, Meijer GA. 2007a. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 211:45-51.
4. Buffart TE, Tijssen M, Krugers T, Carvalho B, Smeets SJ, Brakenhoff RH, Grabsch H, Meijer GA, Sadowski HB, Ylstra B. 2007b. DNA quality assessment for array CGH by isothermal whole genome amplification. Cell Oncol 29:351-359.
5. Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, Bartnitzke S. 1993. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: Correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65:27-31.
6. Cameron HM, Hamperl H, Warambo W. 1974. Leiomyosarcoma of the breast originating from myothelium (myoepithelium). J Pathol 114:89-92.
7. Coe BP, Ylstra B, Carvalho B, Meijer GA, MacAulay C, Lam WL. 2007. Resolving the resolution of array CGH. Genomics 89:647-653.
8. Collins C, Volik S, Kowbel D, Ginzinger D, Ylstra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo WL, Alberts A, Gray JW. 2001. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 11:1034-1042.
9. Crissman JD, Wirman JA, Harris A. 1977. Malignant myoepithelioma of the parotid gland. Cancer 40:3042-3049.
10. Da Silveira EJ, Pereira AL, Fontora MC, De Souza LB, De Almeida FR. 2006. Myoepithelioma of minor salivary gland-an immunohistochemical analysis of four cases. Rev Bras Otorrinolaringol (Engl Ed) 72:528-532.
11. Dardick I. 1985. A role for electron microscopy in salivary gland neoplasms. Ultrastruct Pathol 9:151-161.
12. Dardick I, Cavell S, Boivin M, Hoppe D, Parks WR, Stinson J, Yamada S, Burns BF. 1989. Salivary gland myoepithelioma variants. Histological, ultrastructural, and immunocytological features. Virchows Arch A Pathol Anat Histopathol 416:25-42.
13. De Vries S, Nyante S, Korkola J, Segraves R, Nakao K, Moore D, Bae H, Wilhelm M, Hwang S, Waldman F. 2005. Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. J Mol Diagn 7:65-71.
14. El Naggar AK, Lovell M, Callender DL, Ordonez NG, Killary AM. 1999. Cytogenetic analysis of a primary salivary gland myoepithelioma. Cancer Genet Cytogenet 113:49-53.
15. Ellis GL, Auclair PL. 1996. Tumors of the Salivary Glands. Atlas of Tumor Pathology, 3rd series, Fasicle 17. Washington D.C: Armed Forces Institute of Pathology. 266 p.
16. Fan CK. 2006. Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 533:110-117.
17. Franchi A, Gallo O, Bocciolini C, Franchi L, Paglierani M, Santucci M. 1999. Reduced E-cadherin expression correlates with unfavorable prognosis in adenoid cystic carcinoma of salivary glands of the oral cavity. Am J Clin Pathol 111:43-50.
18. Fu JF, Hsu JJ, Tang TC, Shih LY. 2003. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer 37:214-219.
19. Grasser KD. 2003. Chromatin-associated HMGA and HMGB proteins: Versatile co-regulators of DNA-dependent processes. Plant Mol Biol 53:281-295.
20. Hamperl H. 1970. The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol 53:161-220.
21. Han SU, Lee HY, Lee JH, Kim WH, Nam H, Kim H, Cho YK, Kim MW, Lee KU. 2005. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Ann Surg 242:676-683.
22. Hungermann D, Roeser K, Buerger H, Jakel T, Loening T, Herbst H. 2002. Relative paucity of gross genetic alterations in myoepitheliomas and myoepithelial carcinomas of salivary glands. J Pathol 198:487-494.
23. Italiano A, Cardot N, Dupre F, Monticelli I, Keslair F, Piche M, Mainguene C, Coindre JM, Pedeutour F. 2007. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: The ''missing link'' between lipomas and liposarcomas? Int J Cancer 121:308-315.
24. Jones C, Foschini MP, Chaggar R, Lu YJ, Wells D, Shipley JM, Eusebi V, Lakhani SR. 2000. Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab Invest 80:831-836.
25. Jong K, Marchiori E, Van der Vaart A, Chin SF, Carvalho B, Tijssen M, Eijk PP, Van den Ijssel P, Grabsch H, Quirke P, Oudejans JJ, Meijer GA, Caldas C, Ylstra B. 2007. Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 26:1499-1506.
26. Lakhani SR, O'Hare MJ. 2001. The mammary myoepithelial cell- Cinderella or ugly sister? Breast Cancer Res 3:1-4.
27. Li L, Yee C, Beavo JA. 1999. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283:848-851.
28. Magrini E, Pragliola A, Farnedi A, Betts CM, Cocchi R, Foschini MP. 2004. Cytogenetic analysis of myoepithelial cell carcinoma of salivary gland. Virchows Arch 444:82-86.
29. Martins C, Fonseca I, Felix A, Roque L, Soares J. 1995. Benign salivary gland tumors: A cytogenetic study of 21 cases. J Surg Oncol 60:232-237.
30. Martins C, Fonseca I, Roque L, Pinto AE, Soares J. 1996. Malignant salivary gland neoplasms: A cytogenetic study of 19 cases. Eur J Cancer B Oral Oncol 32B:128-132.
31. Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, Nakahara M, Takada K. 1996. Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours. J Pathol 178:429-436.
32. Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, Fujihara M, Takada K. 1997. Immunohistochemical localization of fibroblast growth factor-1 (FGF-1), FGF-2 and fibroblast growth factor receptor-1 (FGFR-1) in pleomorphic adenoma of the salivary glands. J Oral Pathol Med 26:17-22.
33. Ntougkos E, Rush R, Scott D, Frankenberg T, Gabra H, Smyth JF, Sellar GC. 2005. The IgLON family in epithelial ovarian cancer: Expression profiles and clinicopathologic correlates. Clin Cancer Res 11:5764-5768.
34. Odero MD, Grand FH, Iqbal S, Ross F, Roman JP, Vizmanos JL, Andrieux J, Lai JL, Calasanz MJ, Cross NC. 2005. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 19:245-252.
35. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:557-572.
36. Persson F, Winnes M, Andren Y, Wedell B, Dahlenfors R, Asp J, Mark J, Enlund F, Stenman G. 2007. High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes. Oncogene 27:3072-3080.
37. Rao PH, Murty VV, Louie DC, Chaganti RS. 1998. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. Cancer Genet Cytogenet 105:160-163.
38. Roijer E, Nordkvist A, Strom AK, Ryd W, Behrendt M, Bullerdiek J, Mark J, Stenman G. 2002. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol 160:433-440.
39. Sakamoto I, Ohwada S, Toya H, Togo N, Kashiwabara K, Oyama T, Nakajima T, Ito H, Adachi S, Jigami T, Akiyama T. 2007. Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma. Cancer Sci 98:83-87.
40. Sandros J, Mark J, Happonen RP, Stenman G. 1988. Specificity of 6q- markers and other recurrent deviations in human malignant salivary gland tumors. Anticancer Res 8:637-643.
41. Sandros J, Stenman G, Mark J. 1990. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 44:153-167.
42. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den BH, Van de Ven WJ. 1995. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-444.
43. Sciubba JJ, Brannon RB. 1982. Myoepithelioma of salivary glands: Report of 23 cases. Cancer 49:562-572.
44. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG. 2001. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29:263-264.
45. Stenman G. 2005. Fusion oncogenes and tumor type specificity- insights from salivary gland tumors. Semin Cancer Biol 15:224-235.
46. Strehl S, Glatt K, Liu QM, Glatt H, Lalande M. 1998. Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Genomics 53:81-89.
47. Tumminello M, Lillo F, Mantegna RN. 2007. Kullback-Leibler distance as a measure of the information filtered from multivariate data. Phys Rev E Stat Nonlin Soft Matter Phys 76:031123.
48. Van de Wiel MA, Kim KI, Vosse SJ, Van Wieringen WN, Wilting SM, Ylstra B. 2007. CGHcall: Calling aberrations for array CGH tumor profiles. Bioinformatics 23:892-894.
49. Van de Wiel MA, Smeets SJ, Brakenhoff RH, Ylstra B. 2005. CGHMultiArray: Exact p-values for multi-array CGH-data. Bioinformatics 21:3193-3194.
50. Van de Wiel MA, Van Wieringen WN. 2007. CGHregions: Dimension reduction for Array CGH data with minimal information loss. Cancer Inform 2:55-63.
51. Van Wieringen WN, Van de Wiel MA, Ylstra B. 2008. Weighted clustering of called array CGH data. Biostatistics 9:484-500.
52. Vékony H, Ylstra B, Wilting SM, Meijer GA, Van de Wiel MA, Leemans CR, Van der Waal I, Bloemena E. 2007. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res 13:3133-3139.
53. Willenbrock H, Fridlyand J. 2005. A comparison study: Applying segmentation to array CGH data for downstream analyses. Bioinformatics 21:4084-4091.
54. Wittmann BM, Wang N, Montano MM. 2003. Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Res 63:5151-5158.
55. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61:249-255.